In conclusion, while mutp53 reactivation compounds show promise in cancer therapy, further research is needed to deepen our understanding of their mechanisms, the variability of responses across different cell types, and the optimal level of p53 reactivation necessary for sustained therapeutic effects. The gene discussed is TP53; the disease is cancer.